Arthur D. Levinson — Board Member Accountability Profile
Last updated: October 22, 2026
Category: Private Citizen — Corporate Director Role: Lead Independent Director, Apple Inc. (AAPL) Board Tenure: 2000 – present (Chair, 2011 – August 31, 2026; Lead Independent Director since September 1, 2026) Committee Memberships: People and Compensation Committee Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)
Basis for Inclusion: Arthur D. Levinson holds a documented governance role as a director of Apple Inc., which made documented political donations to Trump-aligned entities while facing an active DOJ antitrust lawsuit and multiple NLRB enforcement actions. He has been Apple’s Lead Independent Director since September 1, 2026, and chaired its board from 2011 through August 31, 2026. His seat on the board of a documented corporate donor is the basis for inclusion (Anchor B): as a director, Levinson shares in the board’s oversight of the corporate decisions documented in the parent corporate donor profile. This profile documents the factual governance relationship, not the subject’s personal political views.
Subject Classification: Private Citizen / Corporate Director. Board membership is a matter of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.
What is NOT the basis for inclusion: Levinson’s personal political opinions, party affiliation, public statements, or any protected speech are NOT the basis for inclusion. The basis is solely the documented board seat and its fiduciary connection to corporate political spending documented in the parent corporate donor profile.
Biographical Overview
Arthur D. Levinson, Ph.D. is the CEO of Calico, a research and development company focused on human aging and age-related diseases, which he has led since 2013. Calico is an Alphabet/Google-backed venture, giving Levinson a notable cross-sector governance position as a director of Apple while leading an Alphabet subsidiary. Before Calico, Levinson served as CEO of Genentech from 1995 to 2009 and as Chairman from 1999 to 2014, where he helped build one of the world’s most important biotechnology companies before its acquisition by Roche.
Levinson is a National Medal of Technology and Innovation recipient and is inducted into the Biotechnology Hall of Fame. He joined the Apple board in 2000 and became Chair in November 2011 following Steve Jobs’ death. He is a trustee of the Broad Institute and Memorial Sloan Kettering Cancer Center.
He holds a B.S. in Molecular Biology from the University of Washington and a Ph.D. in Biochemistry from Princeton University.
Board Role and Governance Authority
- Company: Apple Inc. (NASDAQ: AAPL)
- Board tenure: 2000 – present; Board Chair, November 2011 – August 31, 2026; Lead Independent Director since September 1, 2026
- Committee assignments: People and Compensation Committee
- Day job: CEO, Calico (Alphabet-backed research company)
SourceApple Inc., Form 8-K (Item 5.02), filed April 20, 2026; SEC EDGAR accession 0001140361-26-015711. https://www.sec.gov/Archives/edgar/data/320193/000114036126015711/ef20071035_8k.htm
Other Current Board Memberships
- Calico (Alphabet-backed; CEO)
- Broad Institute — trustee
- Memorial Sloan Kettering Cancer Center — trustee
Parent Corporate Donor Profile
This profile is a governance-accountability companion to the Apple — Corporate Donor Profile, which documents the corporation’s political spending, pending government business, and favorable outcomes under the Trump administration.
Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@citizenanalyst.ai with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.
Investigative trail pointers (public records)
Education only — verify independently. Absence of hits is not proof.
| Channel | Starting points |
|---|---|
| Federal courts | CourtListener / PACER party and attorney searches (spelling variants) |
| Campaign finance | FEC + OpenSecrets for committees and donors tied to documented roles |
| Corporate / LLC | State secretary of state; OpenCorporates for cross-border shells from reporting |
| Sanctions / PEP | OpenSanctions when international business context is already sourced |
| Contracts / grants | USAspending.gov for named entities from investigations |
Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.
Sources
- Apple Inc. DEF 14A Proxy Statement, filed January 2026 (2026 annual meeting)
- SEC EDGAR filing: Apple Inc. (CIK 320193) (SEC EDGAR filings)
- Apple Inc., Form 8-K (Item 5.02), filed April 20, 2026; SEC EDGAR accession 0001140361-26-015711: https://www.sec.gov/Archives/edgar/data/320193/000114036126015711/ef20071035_8k.htm
